| Literature DB >> 28764680 |
Baptiste Couvy-Duchesne1,2,3, Tracey A Davenport4, Nicholas G Martin5, Margaret J Wright6, Ian B Hickie4.
Abstract
BACKGROUND: The Somatic and Psychological HEalth REport (SPHERE) is a 34-item self-report questionnaire that assesses symptoms of mental distress and persistent fatigue. As it was developed as a screening instrument for use mainly in primary care-based clinical settings, its validity and psychometric properties have not been studied extensively in population-based samples.Entities:
Keywords: Anxiety; Chronic fatigue; DSM-IV; Depression; Heritability; Non-parametric item response theory; Psychometrics; Test-retest; Twins
Mesh:
Year: 2017 PMID: 28764680 PMCID: PMC5540428 DOI: 10.1186/s12888-017-1420-1
Source DB: PubMed Journal: BMC Psychiatry ISSN: 1471-244X Impact factor: 3.630
Fig. 1Items and scales of the SPHERE-34. Items’ short names are used through this manuscript. Some items may be included in several scales as indicated by multiple “x” in some rows. Items from the shorter SPHERE-12 appear in blue. Each scale of the SPHERE-12 comprises six items, which were created to provide a screening tool for common psychological and somatic distress in general practice [1, 85–87]. The two dimensional picture of the Australian population for the SPHERE-12 showed good psychometric properties and very high sensitivity for current and life-time major depression, anxiety and neurasthenia as assessed by DSM-III and DSM-IV [1, 86]. In addition, it was a good predictor of disability (as measured using the Brief Disability Questionnaire [88]), psychiatric morbidity [89] and doctor’s rating of psychological risk [1], which has led to its use in research and medical practice in Australia [97]
Fig. 2Venn diagram of the four waves of the BLTS that included the SPHERE-34
Demographics of the full samples and sub-samples pruned for relatedness and/or longitudinal observations
| Wave |
| Mean age | SD | Age range | % Females |
|---|---|---|---|---|---|
| TW1 | 1695 | 12.64 | 1.33 | 9–18 | 51% |
| TW1 pruned for relatedness | 651 | 12.63 | 1.34 | 10–19 | 51% |
| TW2 | 1265 | 14.03 | 0.68 | 9–18 | 50% |
| TW2 pruned | 602 | 14.02 | 0.68 | 10–18 | 50% |
| TM | 1513 | 16.49 | 0.84 | 15–22 | 54% |
| TM pruned | 683 | 16.48 | 0.83 | 16–22 | 53% |
| TA | 1213 | 18.06 | 3.07 | 11–28 | 56% |
| TA pruned | 592 | 18.27 | 3.13 | 12–26 | 56% |
| TA + TM pruned –one assessment wave/ individual | 1117 | 55% | |||
| TA subset | 543 | 18.67 | 3.02 | 12–26 | 56% |
| TM subset | 574 | 16.42 | 0.78 | 16–22 | 54% |
| TA + TW2 pruned | 1012 | 52% | |||
| TA subset | 506 | 18.93 | 2.98 | 12–26 | 56% |
| TW2 subset | 506 | 14.10 | 0.52 | 10–16 | 47% |
| TA + TW1 pruned | 1149 | 53% | |||
| TA subset | 585 | 18.39 | 3.12 | 12–26 | 55% |
| TW1 subset | 564 | 12.50 | 1.15 | 10–19 | 50% |
Fig. 3Protocol for SPHERE-34 scale development in the TA study
Fig. 4Protocol to study and limit DIF across sex groups and waves
Sample size and demographics for genetic analyses
| Age Bins: | 8 to 12 years | 13 to 14 years | 15 to 16 years | 17 to 28 years | ||
|---|---|---|---|---|---|---|
| Total number of observations | 1492 | 1552 | 1683 | 959 | ||
| Number of repeated observations excluded (same participant with two questionnaires in age bin) | 53 | 154 | 108 | 25 | ||
| Number of observations from identical triplet or extra siblings (excluded) | 57 | 27 | 67 | 47 | ||
| Final sample size (individuals) for genetic analyses | 1382 | 1371 | 1508 | 887 | ||
| Incl. | N complete twin pairs | 634 | 603 | 670 | 242 | |
| Incl. | N MZ pairs | 226 | 209 | 230 | 96 | |
| N DZ pairs | 408 | 394 | 440 | 146 | ||
| N extra sibling | 84 | 114 | 89 | 62 | ||
| N twin-sibling pair | 1 | 1 | 0 | 23 | ||
| N singletons | 28 | 49 | 79 | 295 | ||
| Incl. | N twins | 8 | 8 | 15 | 96 | |
| N siblings | 20 | 41 | 64 | 199 | ||
| Mean age (SD) [range] | 12.09 (0.41) [ | 14.15 (0.31) [ | 16.16 (0.37) [ | 19.69 (1.92) [ | ||
| % Females | 50% | 50% | 54% | 58% | ||
Sample size, demographics and prevalence of individuals with SPHERE-34 and CIDI
| 8 to 12 years | 13 to 14 years | 15 to 16 years | 17 to 28 years | ||
|---|---|---|---|---|---|
| N stratified by age at SPHERE-34 assessment | 709 | 907 | 1055 | 739 | |
| Demographics | |||||
| Mean age at CIDI (SD) | 21.9 (1.7) | 22.9 (2.4) | 23.2 (2.5) | 28.9 (3.1) | |
|
| 415 (59%) | 522 (58%) | 641 (61%) | 453 (61%) | |
| Prevalence | |||||
| MDD |
| 118 (16.6%) | 150 (16.5%) | 172 (16.3%) | 119 (16.1%) |
| Mean age onset (SD) | 17.6 (3.1) | 18.2 (3.5) | 18.9 (3.4) | 22.7 (5.3) | |
| Social anxiety |
| 133 (18.7%) | 157 (17.3%) | 182 (17.3%) | 115 (15.5%) |
| Mean age onset (SD) | 12.2 (4.5) | 12.4 (4.7) | 11.9 (5.0) | 12.2 (5.5) | |
| Alcohol dependence |
| 169 (23.8%) | 249 (27.4%) | 300 (28.4%) | 188 (25.4%) |
| Marijuana dependence |
| 37 (5.2%) | 59 (6.5%) | 55 (5.2%) | 30 (4.1%) |
| Panic disorder |
| 4 (0.6%) | 7 (0.8%) | 10 (0.9%) | 3 (0.4%) |
| Mean age onset (SD) | 17.0 (2.7) | 16.6 (2.9) | 16.4 (3.8) | 22.0 (3.6) | |
|
| 13 (1.8%) | 13 (1.4%) | 12 (1.1%) | 15 (2.1%) | |
| Mean age onset (SD) | 14.9 (3.6) | 15.1 (4.1) | 16.6 (4.8) | 20.8 (3.8) | |
Fig. 5Response Step Functions of the 14 items proposed to measure anxiety-depression. For each item, two IRSF are calculated that correspond to the probability of having the symptom more than often (dark blue line) and the probability of having the symptom most of the time (light blue line). Dotted lines correspond to the 95% confidence interval of the IRSF. Using NIRT estimation, we do not constrain the IRSF to be logistic
Fig. 6Difficulty and discrimination of the 20 items suitable for the anxiety-depression scale. The first principal component corresponds to the difficulty of the items, the easiest items being on the right (items 26 and 23). The second principal component measures the items’ discrimination (item 2 being the most discriminant)
Fig. 8Difficulty and discrimination of the 11 items suitable for the somatic distress scale. The first principal component corresponds to the difficulty of the items, the easiest items being on the left (items 22 and 32). The second principal component measures the items’ discrimination (item 29 being the most discriminant, 1 the least discriminant). Added items appear in red
Fig. 7Response Step Functions of the 11 items suitable for the chronic fatigue scale
Fig. 9Summary of NIRT item validation and selection. Items from the original scales are indicated by an x. Items included in the new version of the scales are indicated by a rectangle of colour. Items not present in any scale after the reduction to 21 items appear in light grey
Mean SPHERE-21 IRT and sum score for each scale, wave and sex group
| Mean (SD) | Mean Females (SD) | Mean Males (SD) | Sex difference | ||
|---|---|---|---|---|---|
| TA | |||||
| Anxiety-depression | IRT score | −0.39 (1.6) | −0.27 (1.6) | −0.56 (1.7) |
|
| Sum score | 4.6 (4.8) | 5.0 (4.9) | 4.2 (4.6) |
| |
| Chronic fatigue | IRT score | −0.24 (1.5) | −0.19 (1.4) | −0.30 (1.5) | 0.087 |
| Sum score | 3.9 (3.4) | 3.9 (3.4) | 3.8 (3.5) | 0.37 | |
| TM | |||||
| Anxiety-depression | IRT score | −0.44 (1.7) | −0.25 (1.7) | −0.67 (1.6) |
|
| Sum score | 4.1 (4.5) | 4.7 (5.0) | 3.3 (3.7) |
| |
| Chronic fatigue | IRT score | −0.22 (1.5) | −0.15 (1.5) | −0.31 (1.4) | 0.042 |
| Sum score | 4.0 (3.4) | 4.2 (3.6) | 3.7 (3.2) | 0.018 | |
| TW2 | |||||
| Anxiety-depression | IRT score | −0.47 (1.7) | −0.47 (1.7) | −0.46 (1.7) | 0.88 |
| Sum score | 3.7 (4.3) | 3.7 (4.2) | 3.7 (4.4) | 0.96 | |
| Chronic fatigue | IRT score | −0.28 (1.5) | −0.38 (1.5) | −0.18 (1.5) | 0.031 |
| Sum score | 3.6 (3.3) | 3.4 (3.3) | 3.8 (3.3) | 0.079 | |
| TW1 | |||||
| Anxiety-depression | IRT score | −0.4 (1.6) | −0.48 (1.7) | −0.30 (1.6) | 0.026 |
| Sum score | 4.1 (4.4) | 3.9 (4.3) | 4.4 (4.5) | 0.023 | |
| Chronic fatigue | IRT score | −0.33 (1.6) | −0.48 (1.6) | −0.18 (1.5) |
|
| Sum score | 3.5 (3.3) | 3.3 (3.3) | 3.8 (3.4) |
| |
Here, we performed eight tests yielding a (conservative) Bonferonni-corrected significance threshold of 0.0063. Significant p-values after multiple testing correction appear in bold. All participants were used to produce this table. Relatedness was accounted for using mixed models when testing sex-differences
Cronbach’s alpha and Loevinger’s Coefficients of the SPHERE-21 anxiety-depression and chronic fatigue scales
| TW1 | TW2 | TM | TA | ||
|---|---|---|---|---|---|
| Anxiety-depression | alpha | 0.88 | 0.87 | 0.87 | 0.86 |
| # Hij < 0 | 0 | 0 | 0 | 0 | |
| Min(Hi) | 0.29 | 0.24 | 0.28 | 0.24 | |
| Items Hi < 0.3 | 3 | 3, 28 | 28 | 3 | |
| Chronic fatigue | alpha | 0.79 | 0.79 | 0.78 | 0.79 |
| # Hij < 0 | 0 | 0 | 0 | 0 | |
| Min(Hi) | 0.24 | 0.26 | 0.25 | 0.23 | |
| Items with Hi < 0.3 | 3, 15 | 3, 15, 31 | 3, 15 | 3, 15, 32 |
Alpha corresponds to Cronbach’s alpha; #Hij < 0 to the number of pairwise Loevinger’s Coefficient below 0 for (i,j) items; Min(Hi) is the minimal Loevinger’s Coefficient between an item i and the scale; Items Hi < 0.3 lists the item number corresponding to Hi < 0.3
Summary of variance component analysis (AE models and twin pair correlations)
| Parameter Estimates | Twin pair correlations | |||
|---|---|---|---|---|
| A | E | rMZ | rDZ | |
| Anxiety depression | ||||
| 8–12 years |
|
| 0.43 | 0.22 |
| 13–14 years | 0.42 [0.33,0.5] | 0.58 [0.5,0.67] | 0.38 | 0.32 |
| 15–16 years | 0.29 [0.2,0.38] | 0.71 [0.62,0.8] | 0.28 | 0.20 |
| 17–28 years |
|
| 0.39 | 0.18 |
| Chronic fatigue | ||||
| 8–12 years |
|
| 0.42 | 0.25 |
| 13–14 years |
|
| 0.53 | 0.29 |
| 15–16 years |
|
| 0.38 | 0.15 |
| 17–28 years |
|
| 0.27 | 0.07 |
Estimates of proportion of variance explained by additive genetics (A) and unique environment (E) calculated from AE models. When AE was the “best model” (i.e. most parsimonious model with no significant difference of fit with full model) the parameters appear in bold. Full tables that include ACE, ADE estimates and model fit comparison are available in Additional file 20
Fig. 10Heritability of anxiety-depression and chronic fatigue scores across age. Bars indicate 95% confidence intervals. Estimates and confidence intervals correspond to the ones from AE models
Fig. 11Risks of MDD, social anxiety and substance dependence increases with anxiety-depression IRT scores. p-values are indicated above 95% confidence intervals. The stars correspond to significance after correcting for multiple testing (Bonferonni correction). *corresponds to pcorrected < 0.05, **pcorrected < 0.01 and ***pcorrected < 0.001
Fig. 12Risks of MDD, social anxiety and substance dependence increases with chronic fatigue IRT scores. p-values are indicated above 95% confidence intervals. The stars correspond to significance after correcting for multiple testing (Bonferonni correction). *corresponds to pcorrected < 0.05, **pcorrected < 0.01 and ***pcorrected < 0.001
Comparative psychometric properties of the SPHERE-21 and BDI
| SPHERE-21 | BDI | |
|---|---|---|
| Number of items | 14 (for anxiety-depression) | 21 |
| Short form for clinical use | SPHERE-12 (six items for anxiety-depression) | BDI-11 |
| IRT requirements | Monotonicity verified | Monotonicity breached for items 9 and 10 |
| Sex DIF | Limited (DIF < 0.25) | Large DIF for item 14 (DIF = 0.32) Limited otherwise (DIF < 0.25) [ |
| Age group DIF | Limited (DIF < 0.25); comparable construct from age 9 to 28 years | Not tested at item level (IRT) |
| Language(s) | Arabic, Cantonese, Croatian, Dutch, English, Greek, Italian, Japanese, Mandarin, Portuguese, Serbian, Spanish, Turkish, Vietnamesea | Arabic, Chinese, English, Farsi, Finnish, French, German, Japanese, Korean, Norwegian, Portuguese, Spanish, Swedish, Turkish |
| Test-retest | 0.47 [0.23,0.66] at three months | 0.48–0.86 [ |
| Cronbach’s alpha | 0.87 | 0.81 [ |
| Heritability | 0.41 [0.32,0.49] between ages nine and 12 years, 0.42 [0.33,0.50] at 13 to 14 years, 0.29 [0.20,0.38] at 15 to 16 years and 0.37 [0.21,0.51] between ages 17 and 28 years | 0.18 [0.05,0.31] |
| Association with DSM-IV diagnoses | Significant from age 15 years with alcohol and Marijuana dependence; and from age 13 years for MDD and social anxiety (anxiety-depression subscale). | Not evaluated in general population |
| Price | Free | Around 2 USD per questionnaire [ |
aQuestionnaires in non-English languages available on demand. Please contact Pr. Ian Hickie (ian.hickie@sydney.edu.au)
Here, we used the BDI questionnaire as gold standard as it is one of the oldest, most used and most tested depression questionnaire. For other widely used questionnaires such as the Achenbach or Hamilton rating scales, some the methods used here (e.g. NIRT modelling, twin models) have never been applied, which makes the comparison less meaningful